FI942878A0 - Pyrofeoforbideja ja niiden käyttö valovaikutushoidossa - Google Patents
Pyrofeoforbideja ja niiden käyttö valovaikutushoidossaInfo
- Publication number
- FI942878A0 FI942878A0 FI942878A FI942878A FI942878A0 FI 942878 A0 FI942878 A0 FI 942878A0 FI 942878 A FI942878 A FI 942878A FI 942878 A FI942878 A FI 942878A FI 942878 A0 FI942878 A0 FI 942878A0
- Authority
- FI
- Finland
- Prior art keywords
- compounds
- normal tissues
- photodynamic therapy
- pyropheophorbides
- tumor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0485—Porphyrins, texaphyrins wherein the nitrogen atoms forming the central ring system complex the radioactive metal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Radiation-Therapy Devices (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/822,409 US5198460A (en) | 1988-07-20 | 1992-01-17 | Pyropheophorbides and their use in photodynamic therapy |
PCT/US1993/000060 WO1993013769A1 (en) | 1992-01-17 | 1993-01-07 | Pyropheophorbides and their use in photodynamic therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
FI942878A0 true FI942878A0 (fi) | 1994-06-16 |
FI942878A FI942878A (fi) | 1994-06-16 |
Family
ID=25235954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI942878A FI942878A (fi) | 1992-01-17 | 1994-06-16 | Pyrofeoforbideja ja niiden käyttö valovaikutushoidossa |
Country Status (9)
Country | Link |
---|---|
US (1) | US5198460A (fi) |
EP (2) | EP0623020A4 (fi) |
JP (2) | JP3421991B2 (fi) |
CA (1) | CA2125189C (fi) |
FI (1) | FI942878A (fi) |
NO (1) | NO302173B1 (fi) |
SK (1) | SK279590B6 (fi) |
TW (1) | TW267169B (fi) |
WO (1) | WO1993013769A1 (fi) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5002962A (en) * | 1988-07-20 | 1991-03-26 | Health Research, Inc. | Photosensitizing agents |
USRE38994E1 (en) | 1988-07-20 | 2006-02-28 | Health Research, Inc. | Pyropheophorbides conjugates and their use in photodynamic therapy |
USRE39094E1 (en) | 1988-07-20 | 2006-05-09 | Health Research, Inc. | Pyropheophorbides and their use in photodynamic therapy |
US5492924A (en) * | 1993-09-24 | 1996-02-20 | Fox Chase Cancer Center | Phorbine derivatives and their use in the diagnosis and therapy of cancer |
DE69422014T2 (de) * | 1994-02-03 | 2000-07-20 | Procter & Gamble | Saure Reinigungszusammensetzungen |
US5591847A (en) * | 1994-05-23 | 1997-01-07 | Health Research, Inc. | Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages |
US5599831A (en) * | 1994-05-27 | 1997-02-04 | Poretz; Ronald D. | Method of preparation of pharmaceutical compositions |
US5660181A (en) * | 1994-12-12 | 1997-08-26 | Physical Optics Corporation | Hybrid neural network and multiple fiber probe for in-depth 3-D mapping |
US6316007B1 (en) * | 1995-04-04 | 2001-11-13 | Wound Healing Of Oklahoma | Combined physical and immunotherapy for cancer |
WO1996031237A2 (en) * | 1995-04-04 | 1996-10-10 | Wound Healing Of Oklahoma | Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant |
US5912257A (en) * | 1995-09-06 | 1999-06-15 | The Research Foundation Of State University Of New York | Two-photon upconverting dyes and applications |
WO2000000204A1 (en) * | 1997-02-14 | 2000-01-06 | Miravant Pharmaceuticals, Inc. | Indium photosensitizers for pdt |
US6103751A (en) * | 1998-06-22 | 2000-08-15 | Health Research, Inc. | Carotene analogs of porphyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents |
US5973141A (en) * | 1998-11-27 | 1999-10-26 | Miravant Pharmaceuticals, Inc. | Method for the demethoxycarbonylation of porphyrinic compounds such as pheophorbides |
US9192780B2 (en) | 1998-11-30 | 2015-11-24 | L'oreal | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
US20060212025A1 (en) | 1998-11-30 | 2006-09-21 | Light Bioscience, Llc | Method and apparatus for acne treatment |
US6283956B1 (en) | 1998-11-30 | 2001-09-04 | David H. McDaniels | Reduction, elimination, or stimulation of hair growth |
US6887260B1 (en) | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
US6344050B1 (en) * | 1998-12-21 | 2002-02-05 | Light Sciences Corporation | Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue |
US6376483B1 (en) | 1999-05-27 | 2002-04-23 | Miravant Pharmaceuticals, Inc. | Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production |
US7078014B2 (en) * | 1999-12-23 | 2006-07-18 | Health Research, Inc. | Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
US7897140B2 (en) * | 1999-12-23 | 2011-03-01 | Health Research, Inc. | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents |
US7097826B2 (en) * | 1999-12-23 | 2006-08-29 | Health Research, Inc. | Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
US6534040B2 (en) | 1999-12-23 | 2003-03-18 | Health Research, Inc. | Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals |
US6794505B1 (en) * | 2000-03-30 | 2004-09-21 | Miravant Pharmaceuticals, Inc. | Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy |
US6624187B1 (en) * | 2000-06-12 | 2003-09-23 | Health Research, Inc. | Long wave length absorbing bacteriochlorin alkyl ether analogs |
US6462192B2 (en) | 2001-01-23 | 2002-10-08 | Miravant Pharmaceuticals, Inc. | Processes for large scale production of tetrapyrroles |
CA2437561A1 (en) | 2001-02-06 | 2002-08-15 | Qlt Inc. | Use of additional photodynamic therapy in the treatment of choroidal neovasculature |
KR20040048888A (ko) * | 2001-08-22 | 2004-06-10 | 라이트 바이오사이언스 인코포레이티드 | 여드름의 치료방법 및 치료용 장치 |
EP1517684B1 (en) | 2002-06-27 | 2009-07-22 | Health Research, Inc. | Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
AU2003249742A1 (en) | 2002-07-02 | 2004-01-23 | Health Research, Inc. | Efficient synthesis of pyropheophorbide a and its derivatives |
JP2006522660A (ja) | 2003-04-10 | 2006-10-05 | ライト バイオサイエンス,エルエルシー | 細胞増殖及び遺伝子発現を調節するためのフォトモジュレーション方法及び装置 |
JP2004359645A (ja) * | 2003-06-09 | 2004-12-24 | Hitoshi Ito | 抗動脈硬化剤 |
US7057100B2 (en) * | 2003-06-26 | 2006-06-06 | The J.C. Robinson Seed Co. | Inbred corn line W23129 |
US20050149150A1 (en) | 2003-07-31 | 2005-07-07 | Light Bioscience L.L.C. | System and method for the photodynamic treatment of burns, wounds, and related skin disorders |
US20060141049A1 (en) * | 2003-11-12 | 2006-06-29 | Allergan, Inc. | Triamcinolone compositions for intravitreal administration to treat ocular conditions |
US20050101582A1 (en) * | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
AU2005209201B2 (en) | 2004-01-20 | 2010-06-03 | Allergan, Inc. | Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
US8673341B2 (en) | 2004-04-30 | 2014-03-18 | Allergan, Inc. | Intraocular pressure reduction with intracameral bimatoprost implants |
US20050244471A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Estradiol derivative and estratopone containing sustained release intraocular implants and related methods |
US8722097B2 (en) | 2004-04-30 | 2014-05-13 | Allergan, Inc. | Oil-in-water method for making polymeric implants containing a hypotensive lipid |
US20050244478A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Anti-excititoxic sustained release intraocular implants and related methods |
US20050244500A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Intravitreal implants in conjuction with photodynamic therapy to improve vision |
US9498457B2 (en) | 2004-04-30 | 2016-11-22 | Allergan, Inc. | Hypotensive prostamide-containing biodegradable intraocular implants and related implants |
US8591885B2 (en) * | 2004-04-30 | 2013-11-26 | Allergan, Inc. | Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems |
US20050244472A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Intraocular drug delivery systems containing excipients with reduced toxicity and related methods |
US20050244461A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Controlled release drug delivery systems and methods for treatment of an eye |
US8455656B2 (en) | 2004-04-30 | 2013-06-04 | Allergan, Inc. | Kinase inhibitors |
US7771742B2 (en) | 2004-04-30 | 2010-08-10 | Allergan, Inc. | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
US8425929B2 (en) * | 2004-04-30 | 2013-04-23 | Allergan, Inc. | Sustained release intraocular implants and methods for preventing retinal dysfunction |
US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
US7993634B2 (en) | 2004-04-30 | 2011-08-09 | Allergan, Inc. | Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods |
US20050244465A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Drug delivery systems and methods for treatment of an eye |
US8512738B2 (en) | 2004-04-30 | 2013-08-20 | Allergan, Inc. | Biodegradable intravitreal tyrosine kinase implants |
US20050244463A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular vasculopathies |
US20050244462A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Devices and methods for treating a mammalian eye |
US8147865B2 (en) | 2004-04-30 | 2012-04-03 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US20070059336A1 (en) * | 2004-04-30 | 2007-03-15 | Allergan, Inc. | Anti-angiogenic sustained release intraocular implants and related methods |
US20050244466A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Photodynamic therapy in conjunction with intraocular implants |
US20050244458A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular neuropathies |
US8119154B2 (en) * | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
EP1773350B1 (en) * | 2004-07-12 | 2013-05-29 | Allergan, Inc. | Opthalmic compositions for treating ophthalmic conditions |
JP4733126B2 (ja) * | 2004-07-16 | 2011-07-27 | ヘルス リサーチ インコーポレイテッド | 蛍光色素と腫瘍親和性テトラピロールの付加物 |
US20060052286A1 (en) * | 2004-08-13 | 2006-03-09 | Yale University | Factor VII conjugates for selectively treating neovascularization disorders |
WO2006043965A1 (en) * | 2004-10-14 | 2006-04-27 | Allergan, Inc. | Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
US20060223750A1 (en) * | 2005-04-01 | 2006-10-05 | Allergan, Inc. | Agents and methods for enhancing photodynamic therapy |
US20070086949A1 (en) * | 2005-06-20 | 2007-04-19 | Prasad Paras N | Method of bioimaging using nanocrystals of fluorescent dyes |
US8969415B2 (en) | 2006-12-01 | 2015-03-03 | Allergan, Inc. | Intraocular drug delivery systems |
US20100137396A1 (en) * | 2007-01-09 | 2010-06-03 | Health Research, Inc | Treatment of esophageal high grade dysplasia using photodynamic therapy |
US20100144820A1 (en) * | 2007-01-09 | 2010-06-10 | Health Research, Inc. | Therapeutic hpph dosage for pdt |
US7911053B2 (en) * | 2007-04-19 | 2011-03-22 | Marvell World Trade Ltd. | Semiconductor packaging with internal wiring bus |
WO2009038660A1 (en) * | 2007-09-14 | 2009-03-26 | Health Research, Inc. | Multimodality agents for tumor imaging and therapy |
US20100056983A1 (en) * | 2007-09-27 | 2010-03-04 | Health Research, Inc. | Treatment of cancer using photodynamic therapy |
US8829020B2 (en) | 2009-07-16 | 2014-09-09 | Mallinckrodt Llc | Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers |
MX361709B (es) | 2009-11-09 | 2018-12-07 | Allergan Inc | Composiciones y metodos para estimular el crecimiento del cabello. |
US8609837B2 (en) | 2010-07-06 | 2013-12-17 | Health Research, Inc. | Metallation enhancements in tumor-imaging and PDT therapy |
CN103242324B (zh) * | 2012-02-07 | 2016-07-06 | 浙江海正药业股份有限公司 | 2-((1′-正己氧基)乙基)-2-二乙烯基-焦脱镁叶绿酸-a的晶型及其制备方法 |
CN103705532B (zh) * | 2012-10-08 | 2016-09-14 | 浙江海正药业股份有限公司 | 靶向胸苷激酶光敏剂及其药物组合物与治疗癌症的用途 |
JP6511401B2 (ja) | 2013-02-15 | 2019-05-15 | アラーガン、インコーポレイテッドAllergan,Incorporated | 持続型薬物送達インプラント |
CN104193753A (zh) * | 2014-08-26 | 2014-12-10 | 江苏红豆杉药业有限公司 | 一种由红豆杉枝叶提取物制备光敏剂hpph的方法 |
US10035806B2 (en) | 2015-10-06 | 2018-07-31 | California Institute Of Technology | Derivatized corroles and metallocorroles and their use as imaging and therapeutic agents |
CA3033087A1 (en) * | 2016-09-06 | 2018-03-15 | Exxonmobil Research And Engineering Company | Natural antioxidants derived from lignin |
AU2018235945A1 (en) | 2017-03-14 | 2019-10-17 | Ohio State Innovation Foundation | Methods and compositions related to a tissue factor-targeting IgG3 immunoconjugates |
CN108586468B (zh) * | 2018-01-10 | 2020-06-23 | 浙江海正药业股份有限公司 | 一种hpph的纯化方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4649151A (en) * | 1982-09-27 | 1987-03-10 | Health Research, Inc. | Drugs comprising porphyrins |
ATE84036T1 (de) * | 1985-10-23 | 1993-01-15 | Nihon Mediphysics Co Ltd | Porphyrinderivate, ihre herstellung und verwendung. |
US4949151A (en) * | 1986-09-24 | 1990-08-14 | Hitachi, Ltd. | Bipolar transistor having side wall base and collector contacts |
US4883790A (en) * | 1987-01-20 | 1989-11-28 | University Of British Columbia | Wavelength-specific cytotoxic agents |
US4920143A (en) * | 1987-04-23 | 1990-04-24 | University Of British Columbia | Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents |
US5002962A (en) * | 1988-07-20 | 1991-03-26 | Health Research, Inc. | Photosensitizing agents |
-
1992
- 1992-01-17 US US07/822,409 patent/US5198460A/en not_active Ceased
- 1992-12-15 TW TW081110042A patent/TW267169B/zh active
-
1993
- 1993-01-07 JP JP51253193A patent/JP3421991B2/ja not_active Expired - Fee Related
- 1993-01-07 CA CA002125189A patent/CA2125189C/en not_active Expired - Fee Related
- 1993-01-07 WO PCT/US1993/000060 patent/WO1993013769A1/en not_active Application Discontinuation
- 1993-01-07 EP EP93902943A patent/EP0623020A4/en not_active Withdrawn
- 1993-01-07 EP EP01115782A patent/EP1146046A3/en not_active Withdrawn
- 1993-01-07 SK SK768-94A patent/SK279590B6/sk unknown
-
1994
- 1994-06-16 NO NO942283A patent/NO302173B1/no not_active IP Right Cessation
- 1994-06-16 FI FI942878A patent/FI942878A/fi not_active Application Discontinuation
-
2002
- 2002-11-19 JP JP2002335247A patent/JP2003146989A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP3421991B2 (ja) | 2003-06-30 |
AU669876B2 (en) | 1996-06-27 |
EP1146046A2 (en) | 2001-10-17 |
EP0623020A1 (en) | 1994-11-09 |
TW267169B (fi) | 1996-01-01 |
SK279590B6 (sk) | 1999-01-11 |
FI942878A (fi) | 1994-06-16 |
JPH07505614A (ja) | 1995-06-22 |
NO302173B1 (no) | 1998-02-02 |
WO1993013769A1 (en) | 1993-07-22 |
US5198460A (en) | 1993-03-30 |
SK76894A3 (en) | 1995-04-12 |
NO942283L (no) | 1994-06-16 |
EP0623020A4 (en) | 1995-01-25 |
CA2125189A1 (en) | 1993-07-22 |
AU3433793A (en) | 1993-08-03 |
NO942283D0 (no) | 1994-06-16 |
JP2003146989A (ja) | 2003-05-21 |
EP1146046A3 (en) | 2003-02-26 |
CA2125189C (en) | 2005-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI942878A0 (fi) | Pyrofeoforbideja ja niiden käyttö valovaikutushoidossa | |
ATE112680T1 (de) | Photoempfindliche mittel. | |
Kübler | Photodynamic therapy | |
Schuller et al. | Photodynamic therapy in head and neck cancer | |
Goldberg et al. | Q-switched ruby laser treatment of congenital nevi | |
Parrish et al. | Photochemotherapy of vitiligo: Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system | |
Fingar et al. | Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response | |
Babilas et al. | Photodynamic therapy in dermatology: state‐of‐the‐art | |
McCaughan et al. | Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms | |
BR9914969A (pt) | Métodos para formar imagem, tratar e localizar tecido doente, e, dispositivo integrado de formação de imagem e de tratamento | |
Ferguson et al. | Evaluation of the Nd/YAG laser for treatment of amateur and professional tattoos | |
CY1105634T1 (el) | Η χρηση του ραδιου -223 για τη στοχευση ασβεστωμενων ιστων για την ανακουφιση πονου και τη θεραπεια οστικου καρκινου | |
CA2112132A1 (en) | Photodynamic stimulation device | |
Grimes | Psoralen photochemotherapy for vitiligo | |
PT933995E (pt) | Metodo para tratamento de lesao endotelial | |
DK0569113T3 (da) | Liposomsammensætninger af porfyrinfotosensibilatorer | |
Gilson et al. | Therapeutic ratio of photodynamic therapy in the treatment of superficial tumours of skin and subcutaneous tissues in man | |
Meyer et al. | A study of the effects of photodynamic therapy on the normal tissues of the rabbit jaw | |
Rounds et al. | Development of a Protocol for Photoradiation Therapy of Malignant Brain Tumors: Part 1: Photosensitization of Normal Brain Tissue with Hematoporphyrin Derivative | |
Dougherty et al. | Photoradiation therapy of malignant tumors; role of the laser | |
Cheli et al. | Photodynamic therapy of spontaneous animal tumors using the active component of hematoporphyrin derivative (DHE) as photosensitizing drug: Clincal results | |
Kübler et al. | Photodynamic therapy of head and neck cancer | |
Bernstein et al. | Response of black and white guinea pig skin to photodynamic treatment using 514-nm light and dihematoporphyrin ether | |
Hode et al. | Laser phototherapy | |
IL121440A0 (en) | The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |